Simultaneous dystrophin and dysferlin deficiencies associated with high-level expression of the Coxsackie and adenovirus receptor in transgenic mice

American Journal of Pathology

Volumn 169, Issue 6, 2006, Pages 2148-2160

  Shaw, Christian A ^a   Larochelle, Nancy ^a,c   Dudley, Roy W R ^b   Lochmuller, Hanns ^d   Danialou, Gawiyou ^b   Petrof, Basil J ^b   Karpati, George ^a   Holland, Paul C ^a   Nalbantoglu, Josephine ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c Genzentrum   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DYSTROGLYCAN; CAVEOLIN 3; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; DYSFERLIN; DYSTROPHIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE SYNTHASE; COXSACKIE AND ADENOVIRUS RECEPTOR LIKE MEMBRANE PROTEIN, MOUSE; COXSACKIE- AND ADENOVIRUS RECEPTOR-LIKE MEMBRANE PROTEIN, MOUSE; DYSF PROTEIN, MOUSE; MEMBRANE PROTEIN; NEURONAL NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, MOUSE;

ARTICLE; CONTROLLED STUDY; MOUSE; MUSCLE CONTRACTION; MUSCLE ISOMETRIC CONTRACTION; MYOPATHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; ANIMAL; C3H MOUSE; C57BL MOUSE; GENETICS; HEART CONTRACTION; METABOLISM; MUSCLE DISEASE; NEUROMUSCULAR SYNAPSE; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; CAVEOLIN 3; DYSTROPHIN; MEMBRANE PROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYOCARDIAL CONTRACTION; NEUROMUSCULAR JUNCTION; NITRIC OXIDE SYNTHASE TYPE I;

EID: 35549011548     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.060570     Document Type: Article

References (61)

1. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM: Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987, 50:509-517
2. Bonnemann CG, Modi R, Noguchi S, Mizuno Y, Yoshida M, Gussoni E, McNally EM, Duggan DJ, Angelini C, Hoffman EP: Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet 1995, 11:266-273
3. Lim LE, Duclos F, Broux O, Bourg N, Sunada Y, Allamand V, Meyer J, Richard I, Moomaw C, Slaughter C, Tomé FMS, Fardeau M, Jackson CE, Beckmann JS, Campbell KP: Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet 1995, 11:257-265
4. Nigro V, de Sa Moreira E, Piluso G, Vainzof M, Belsito A, Politano L, Puca AA, Passos-Bueno MR, Zatz M: Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat Genet 1996, 14:195-198
5. Duggan DJ, Gorospe JR, Fanin M, Hoffman EP, Angelini C: Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med 1997, 336:618-624
6. Noguchi S, McNally EM, Ben Othmane K, Hagiwara Y, Mizuno Y, Yoshida M, Yamamoto H, Bonnemann CG, Gussoni E, Denton PH, Kyriakides T Middleton L, Hentati F, Ben Hamida M, Nonaka I, Vance JM, Kunkel LM, Ozawa E: Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science 1995, 270:819-822
7. Worton R: Muscular dystrophies: diseases of the dystrophin-glycoprotein complex. Science 1995, 270:755-756
8. Betz RC, Schoser BG, Kasper D, Ricker K, Ramirez A, Stein V, Torbergsen T, Lee YA, Nothen MM, Wienker TF, Malin JP, Propping P, Reis A, Mortier W, Jentsch TJ, Vorgerd M, Kubisch C: Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 2001, 28:218-219
9. Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, Masetti E, Mazzocco M, Egeo A, Donati MA, Volonte D, Galbiati F, Cordone G, Bricarelli FD, Lisanti MP, Zara F: Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 1998, 18:365-368
10. Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, Serrano C, Urtizberea JA, Hentati F, Hamida MB, Bohlega S, Culper EJ, Amato AA, Bossie K, Oeltjen J, Bejaoui K, McKenna-Yasek D, Hosler BA, Schurr E, Arahata K, de Jong PJ, Brown Jr RH: Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998, 20:31-36
11. Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, Lako M, Richard I, Marchand S, Bourg N, Argov Z, Sadeh M, Mahjneh I, Marconi G, Passos-Bueno MR, Moreira Ede S, Zatz M, Beckmann JS, Bushby K: A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 1998, 20:37-42
12. Galbiati F, Volonte D, Chu JB, Li M, Fine SW, Fu M, Bermudez J, Pedemonte M, Weidenheim KM, Pestell RG, Minetti C, Lisanti MP: Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proc Natl Acad Sci USA 2000, 97:9689-9694
13. Zhu X, Hadhazy M, Groh ME, Wheeler MT, Wollmann R, McNally EM: Overexpression of gamma-sarcoglycan induces severe muscular dystrophy. Implications for the regulation of sarcoglycan assembly. J Biol Chem 2001, 276:21785-21790
14. Tomko RP, Xu R, Philipson L: HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 1997, 94:3352-3356
15. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW: Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275:1320-1323
16. Nalbantoglu J, Pari G, Karpati G, Holland PC: Expression of the primary Coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells. Hum Gene Ther 1999, 10:1009-1019
17. Shaw CA, Holland PC, Sinnreich M, Allen C, Sollerbrant K, Karpati G, Nalbantoglu J: Isoform-specific expression of the Coxsackie and adenovirus receptor (CAR) in neuromuscular junction and cardiac intercalated discs. BMC Cell Biol 2004, 5:42
18. Nalbantoglu J, Larochelle N, Wolf E, Karpati G, Lochmuller H, Holland PC: Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle. J Virol 2001, 75:4276-4282
19. Bulfield G, Siller WG, Wight PA, Moore KJ: X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984, 81:1189-1192
20. Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, McNeil PL, Campbell KP: Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003, 423:168-172
21. Straub V, Rafael JA, Chamberlain JS, Campbell KP: Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 1997, 139:375-385
22. Sollerbrant K, Raschperger E, Mirza M, Engstrom U, Philipson L, Ljungdahl PO, Pettersson RF: The Coxsackievirus and adenovirus receptor (CAR) forms a complex with the PDZ domain-containing protein ligand-of-numb protein-X (LNX). J Biol Chem 2003, 278:7439-7444
23. Frank JS, Mottino G, Chen F, Peri V, Holland P, Tuana BS: Subcellular distribution of dystrophin in isolated adult and neonatal cardiac myocytes. Am J Physiol 1994, 267:C1707-C1716
24. Passos-Bueno MR, Rapaport D, Love D, Flint T, Bortolini ER, Zatz M, Davies KE: Screening of deletions in the dystrophin gene with the cDNA probes Cf23a, Cf56a, and Cf115. J Med Genet 1990, 27:145-150
25. Tso JY, Sun XH, Kao TH, Reece KS, Wu R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985, 13:2485-2502
26. Ryder JW, Fahlman R, Wallberg-Henriksson H, Alessi DR, Krook A, Zierath JR: Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle. Involvement of the mitogen- and stress-activated protein kinase 1. J Biol Chem 2000, 275:1457-1462
27. Wretman C, Lionikas A, Widegren U, Lannergren J, Westerblad H, Henriksson J: Effects of concentric and eccentric contractions on phosphorylation of MAPK(erk1/2) and MAPK(p38) in isolated rat skeletal muscle. J Physiol 2001, 535:155-164
28. Dudley RW, Lu Y, Gilbert R, Matecki S, Nalbantoglu J, Petrof BJ, Karpati G: Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helperdependent adenoviral vector. Hum Gene Ther 2004, 15:145-156
29. Bittner RE, Anderson LV, Burkhardt E, Bashir R, Vafiadaki E, Ivanova S, Raffelsberger T, Maerk I, Hoger H, Jung M, Karbasiyan M, Storch M, Lassmann H, Moss JA, Davison K, Harrison R, Bushby KM, Reis A: Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet 1999, 23:141-142
30. Rafael JA, Nitta Y, Peters J, Davies KE: Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice. Mamm Genome 2000, 11:725-728
31. Sinnreich M, Shaw CA, Pari G, Nalbantoglu J, Holland PC, Karpati G: Localization of Coxsackie virus and adenovirus receptor (CAR) in normal and regenerating human muscle. Neuromuscul Disord 2005, 15:541-548
32. Garcia-Cardena G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP, Sessa WC: Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem 1997, 272:25437-25440
33. Venema VJ, Ju H, Zou R, Venema RC: Interaction of neuronal nitricoxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem 1997, 272:28187-28190
34. Matsuda C, Hayashi YK, Ogawa M, Aoki M, Murayama K, Nishino I, Nonaka I, Arahata K, Brown Jr RH: The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet 2001, 10:1761-1766
35. Repetto S, Bado M, Broda P, Lucania G, Masetti E, Sotgia F, Carbone I, Pavan A, Bonilla E, Cordone G, Lisanti MP, Minetti C: Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. Biochem Biophys Res Commun 1999, 261:547-550
36. Razani B, Schlegel A, Lisanti MP: Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy. J Cell Sci 2000, 113:2103-2109
37. Hayashi T, Hirshman MF, Dufresne SD, Goodyear LJ: Skeletal muscle contractile activity in vitro stimulates mitogen-activated protein kinase signaling. Am J Physiol 1999, 277:C701-C707
38. Martineau LC, Gardiner PF: Insight into skeletal muscle mechanotransduction: MAPK activation is quantitatively related to tension. J Appl Physiol 2001, 91:693-702
39. Widegren U, Ryder JW, Zierath JR: Mitogen-activated protein kinase signal transduction in skeletal muscle: effects of exercise and muscle contraction. Acta Physiol Scand 2001, 172:227-238
40. Aronson D, Violan MA, Dufresne SD, Zangen D, Fielding RA, Goodyear LJ: Exercise stimulates the mitogen-activated protein kinase pathway in human skeletal muscle. J Clin Invest 1997, 99:1251-1257
41. Goodyear LJ, Chang PY, Sherwood DJ, Dufresne SD, Moller DE: Effects of exercise and insulin on mitogen-activated protein kinase signaling pathways in rat skeletal muscle. Am J Physiol 1996, 271:E403-E408
42. Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, Lisanti MP: Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett 1998, 428:205-211
43. Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, Shirani J, Tang B, Jelicks LA, Kitsis RN, Christ GJ, Factor SM, Tanowitz HB, Lisanti MP: Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 2002, 277:38988-38997
44. Honda T, Saitoh H, Masuko M, Katagiri-Abe T, Tominaga K, Kozakai I, Kobayashi K, Kumanishi T, Watanabe YG, Odani S, Kuwano R: The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain. Brain Res Mol Brain Res 2000, 77:19-28
45. Bruning A, Runnebaum IB: CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta. Gene Ther 2003, 10:198-205
46. Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, Bergelson JM: The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA 2001, 98:15191-15196
47. Excoffon KJ, Hruska-Hageman A, Klotz M, Traver GL, Zabner J: A role for the PDZ-binding domain of the Coxsackie B virus and adenovirus receptor (CAR) in cell adhesion and growth. J Cell Sci 2004, 117:4401-4409
48. Wan YY, Leon RP, Marks R, Cham CM, Schaack J, Gajewski TF, DeGregori J: Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells. Proc Natl Acad Sci USA 2000, 97:13784-13789
49. Tallone T, Malin S, Samuelsson A, Wilbertz J, Miyahara M, Okamoto K, Poellinger L, Philipson L, Pettersson S: A mouse model for adenovirus gene delivery. Proc Natl Acad Sci USA 2001, 98:7910-7915
50. Schmidt MR, Piekos B, Cabatingan MS, Woodland RT: Expression of a human coxsackie/adenovirus receptor transgene permits adenovirus infection of primary lymphocytes. J Immunol 2000, 165:4112-4119
51. Hurez V, Dzialo-Hatton R, Oliver J, Matthews RJ, Weaver CT: Efficient adenovirus-mediated gene transfer into primary T cells and thymocytes in a new coxsackie/adenovirus receptor transgenic model. BMC Immunol 2002, 3:4
52. Sotgia F, Lee JK, Das K, Bedford M, Petrucci TC, Macioce P, Sargiacomo M, Bricarelli FD, Minetti C, Sudol M, Lisanti MP: Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members. J Biol Chem 2000, 275:38048-38058
53. Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP: Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem 1995, 270:27305-27310
54. Rafael JA, Cox GA, Corrado K, Jung D, Campbell KP, Chamberlain JS: Forced expression of dystrophin deletion constructs reveals structure-function correlations. J Cell Biol 1996, 134:93-102
55. Carpenter S, Karpati G: Pathology of Skeletal Muscle. New York, Oxford University Press, 2001
56. Straub V, Campbell KP: Muscular dystrophies and the dystrophin- glycoprotein complex. Curr Opin Neurol 1997, 10:168-175
57. Karpati G, Carpenter S, Morris GE, Davies KE, Guerin C, Holland P: Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J Neuropathol Exp Neurol 1993, 52:119-128
58. Capanni C, Sabatelli P, Mattioli E, Ognibene A, Columbaro M, Lattanzi G, Merlini L, Minetti C, Maraldi NM, Squarzoni S: Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition. Exp Mol Med 2003, 35:538-544
59. Figarella-Branger D, Pouget J, Bernard R, Krahn M, Fernandez C, Levy N, Pellissier JF: Limb-girdle muscular dystrophy in a 71-year-old woman with an R27Q mutation in the CAV3 gene. Neurology 2003, 61:562-564
60. Kubisch C, Schoser BG, von During M, Betz RC, Goebel HH, Zahn S, Ehrbrecht A, Aasly J, Schroers A, Popovic N, Lochmuller H, Schroder JM, Bruning T, Malin JP, Fricke B, Meinck HM, Torbergsen T, Engels H, Voss B, Vorgerd M: Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease. Ann Neurol 2003, 53:512-520
61. Walter MC, Braun C, Vorgerd M, Poppe M, Thirion C, Schmidt C, Schreiber H, Knirsch UI, Brummer D, Muller-Felber W, Pongratz D, Muller-Hocker J, Huebner A, Lochmuller H: Variable reduction of caveolin-3 in patients with LGMD2B/MM. J Neurol 2003, 250:1431-1438